The First and Only BX Stent Graft Iliac Indication

The GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis (VBX Stent Graft) is the first and only balloon expandable stent graft to receive FDA approval for treatment of de novo or restenotic lesions found in iliac arteries, including lesions at the aortic bifurcation.

Flexible Strength. Proven Success.

The VBX Stent Graft treats iliac occlusive disease with proven procedural success and long-term outcomes through strength, flexibility, and accuracy.

* Data on file. Based on nine month results from the Gore VBX FLEX IDE Clinical Study (N = 134 subjects) and follow-ups conducted for U.S. FDA approval.


Learn more about our Peripheral Portfolio

The GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis adds a new innovative solution to our expanding Peripheral Portfolio, which provides more treatment options for your complex cases. This is the result of a collaborative effort with clinicians to develop advanced offerings designed to meet the needs of patients. Just one more example of how we work to achieve a shared goal. Together. Improving life.

GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis: Additional product features and benefits, configurations, and Instructions for Use

GORE® VIABAHN® Endoprosthesis: View our extremely strong, growing body of clinical data in the category of complex SFA lesions.

GORE® TIGRIS® Vascular Stent: Now FDA Approved - the GORE® TIGRIS® Vascular Stent goes beyond bare metal with advanced technologies to deliver precise placement and conformability in complex anatomies.